Prognosis
Sanofi Drug Raises Hopes of Wiping Out Sleeping Sickness
- Drug cured 95% of people with late-stage forms of the ailment
- Experts hope easy-to-administer drug could eradicate disease
This article is for subscribers only.
A drug co-developed by Sanofi is highly effective at treating the sometimes lethal disease called sleeping sickness and could help eradicate the ailment by the end of the decade.
A single oral dose of acoziborole was 95% effective at curing patients with a late-stage form of the parasitic disease, according to a study published in The Lancet. The drug was co-developed by the Drugs for Neglected Diseases initiative.